QUARTERLY BUSINESS UPDATE FOR THE THIRD QUARTER AND NINE MONTHS ENDED 30 SEPTEMBER 2023 General Announcement Filing viewer · member access Original SGX announcement
COMPLETION OF PROPOSED ACQUISITION OF THE TRANCHE 1 SALE SHARES OF 23% IN ARDENCE PHARMA SDN BHD Asset Acquisitions and Disposals Filing viewer · member access Original SGX announcement
ANALYST BRIEFING- ACQUISITION OF ARDENCE MALAYSIA General Announcement Filing viewer · member access Original SGX announcement
PROPOSED ACQUISITION OF 58% OF THE SHARE CAPITAL IN ARDENCE PHARMA SDN BHD OVER 3 TRANCHES Asset Acquisitions and Disposals Filing viewer · member access Original SGX announcement
NABOTA SUCCESSFULLY REGISTERED IN MALAYSIA General Announcement Filing viewer · member access Original SGX announcement
RESULTS BRIEFING 1H 2023 General Announcement Filing viewer · member access Original SGX announcement
Half Yearly Results Financial Statements and Related Announcement Filing viewer · member access Original SGX announcement
CESSATION OF SUBSTANTIAL SHAREHOLDER'S INTEREST- MR TAN CHWEE CHOON Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) Filing viewer · member access Original SGX announcement
CHANGE OF DIRECTOR'S INTEREST - DR TAN KIA KING Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer Filing viewer · member access Original SGX announcement
CHANGE OF DIRECTOR'S INTEREST - MR LIM SEE WAH Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer Filing viewer · member access Original SGX announcement
CHANGE OF SUBSTANTIAL SHAREHOLDER'S INTEREST - INOMED HOLDING PTE LTD Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s) Filing viewer · member access Original SGX announcement
Appointment of Chief Financial Officer Change - Announcement of Appointment Filing viewer · member access Original SGX announcement
Minutes of Annual General Meeting and Extraordinary General Meeting held on 26 April 2023 General Announcement Filing viewer · member access Original SGX announcement
HYPHENS PHARMA TO DEVELOP AND COMMERCIALISE BYFAVO PROCEDURAL SEDATION DRUG IN SINGAPORE General Announcement Filing viewer · member access Original SGX announcement
BUSINESS UPDATE AND RESULTS BRIEFING FOR THE FIRST QUARTER ENDED 31 MARCH 2023 General Announcement Filing viewer · member access Original SGX announcement
ALLOTMENT AND ISSUANCE OF 422,000 NEW ORDINARY SHARES UNDER THE HYPHENS PERFORMANCE SHARE PLAN Employee Stock Option/ Share Scheme Filing viewer · member access Original SGX announcement
Extraordinary/ Special General Meeting::Voluntary REPL Filing viewer · member access Original SGX announcement
RESPONSE TO QUERIES FROM SECURITIES INVESTORS ASSOCIATION (SINGAPORE) ON ANNUAL REPORT 2022 General Announcement Filing viewer · member access Original SGX announcement
Cessation of an Executive Director Change - Announcement of Cessation Filing viewer · member access Original SGX announcement
Voluntary Extraordinary/ Special General Meeting Filing viewer · member access Original SGX announcement
